Altman Peter 4
4 · BioCardia, Inc. · Filed Jul 8, 2026
Research Summary
AI-generated summary of this filing
BioCardia (BCDA) CEO Peter Altman Buys 5,400 Shares
What Happened
Peter Altman, President, CEO and a director of BioCardia, purchased 5,400 shares of BCDA in an open-market/private purchase on July 8, 2026. The filing reports a weighted-average price of $0.96 per share for a reported total of $5,208. This was a purchase (code P), which is generally viewed as a direct insider buy rather than a sale.
Key Details
- Transaction date: 2026-07-08 (reported same day; filing appears timely)
- Reported price: weighted average $0.96 per share (range of individual trades $0.92–$1.05 per F1)
- Shares acquired: 5,400; reported total value: $5,208
- Shares owned after transaction: Not disclosed in the filing
- Footnote: F1 states the purchase was executed in multiple trades at prices between $0.92 and $1.05; the weighted average is reported and the reporting person will provide per-trade details to the SEC or issuer upon request
Context
Insider purchases can signal confidence but do not by themselves prove future stock performance. This is a small-dollar open-market purchase by the CEO; for more detail on the per-trade prices or post-transaction holdings, investors can request the supplemental information referenced in the filing.
Insider Transaction Report
- Purchase
Common Stock
[F1]2026-07-08$0.96/sh+5,400$5,208→ 361,985 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades ranging from $0.92 to $1.05 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.